TOP STORIES

• ACADEMIA Abortion Pill Is Beneficial as New Option, but Don’t See It as Easy Solution: OB/GYN Association Chair
  April 20, 2023

• REGULATORY Japan to End Priority Review for COVID Drugs and Vaccines after Severity Downgrade: Official
  April 20, 2023

• BUSINESS Ono Aims Higher with Aggressive Open Innovation in Drug Discovery
  April 19, 2023

• BUSINESS Lilly’s Mounjaro Hits Japan Pharmacy Shelves, Mitsubishi as Distributor
  April 19, 2023

• REGULATORY LDP Gathers Steam towards Pharma Policy Proposal Next Month, Sees Honebuto as Make-or-Break Milestone
  April 18, 2023

• REGULATORY Abortion Pill Mefeego’s Japan Panel Review Rescheduled for April 21
  April 18, 2023

• ORGANIZATION Pharma CEOs Call for Japan’s Leadership to Tackle Global Health Issues at G7 Summit
  April 17, 2023

• ORGANIZATION Japan, US, EU Trade Groups Push Price Maintenance during Patent Period: Joint Statement
  April 17, 2023

• BUSINESS AstraZeneca Japan Grows 17% in 2022, Bags 12 Approvals; Up to 7 Filings Eyed for 2023
  April 14, 2023

• BUSINESS Axcelead to Expand Overseas Biz, Shoots for 130 Billion Yen Sales and 5,000-Plus Researchers
  April 13, 2023

• REGULATORY Lawmakers Split 50/50 on Abortion Pill, No Conclusion at LDP Panel
  April 13, 2023

• BUSINESS Novo Japan Sales Renew Record in 2022 as Ozempic, Rybelsus Blossom
  April 12, 2023

• BUSINESS Amgen Eyes Simultaneous Filing in Japan, US, EU for 3 Key Drivers, including Next-Gen BiTE Drug: R&D Chief
  April 11, 2023

• BUSINESS Generic Shipment Price Rate Likely Rose 1.5% for FY2023 Revision, Weighing on Wholesalers
  April 10, 2023

• REGULATORY 9-Valent HPV Vaccine Program Poses Opportunity to Boost Inoculation Rate: LDP Lawmaker
  April 7, 2023

• BUSINESS MSD Japan Nets 24% Growth in 2022 on Lagevrio, Keytruda; President Wary of Further Re-Pricing
  April 6, 2023

• REGULATORY Expert Panel Mixed on Macroeconomic Indexing of Drug Cost; Govt Urged to Quit Targeting Pharma for Savings
  April 5, 2023

• BUSINESS 19 of 41 Drug Makers Log P/B Ratio Below 1; TSE’s Quest to Boost Market Cap Not Easy
  April 4, 2023

• COMMENTARY Some Pharma Makers Leery of Further Cut into Off-Patent Brands in Japan
  April 3, 2023

• BUSINESS Merck Poised to Work Together with Japan towards 90% HPV Vaccine Rate: Exec
  March 31, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 56
• 57
• 58
• 59
• 60
• 61
• 62
• 63
• 64
• …
• Next ›
• 最終 »